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The well-studied enterobacterium Escherichia coli present in the human gut is able to reduce 
TMAO to trimethylamine (TMA) during anaerobic respiration. The TMAO reductase TorA is a 
monomeric, bis-molybdopterin guanine dinucleotide (bis-MGD) cofactor-containing enzyme 
belonging to the dimethylsulfoxide (DMSO) reductase family of molybdoenzymes. We report on 
a system for the in vitro reconstitution of TorA with molybdenum cofactors (Moco) from 
different sources. Higher TMAO reductase activities for TorA were obtained when using Moco-
sources containing a sulfido ligand at the molybdenum atom. For the first time, we were able to 
isolate functional bis-MGD from Rhodobacter capsulatus formate dehydrogenase (FDH), which 
remained intact in its isolated state and after insertion into apo-TorA yielded a highly active 
enzyme. Combined characterizations of the reconstituted TorA enzymes by EPR spectroscopy 
and direct electrochemistry emphasize that TorA activity can be modified by changes in the Mo-
coordination sphere. The combination of these results together with studies on amino acid 
exchanges at the active site led us to propose a novel model for substrate binding to the 




Escherichia coli is a facultative anaerobic bacterium that can adapt to many environmental 
conditions. In particular, E. coli can use several small compounds, including nitrate, 
dimethylsulfoxide (DMSO), or trimethylamine-N-oxide (TMAO), as alternative electron 
acceptors to produce energy.1-3 Under oxygen limitation, TMAO can be used as terminal electron 
acceptor for energy production with a standard redox potential (pH 7.0) for the TMAO/TMA 
couple of +130 mV. 3, 4 In E. coli, the operon composed of the genes torCAD encodes for the 
proteins of the TMAO reductase system, the expression of which is controlled by the presence of 
TMAO.5-7 However, in contrast to other alternative respiratory systems, the expression of TMAO 
reductase is not repressed by the presence of oxygen.5 Instead, in aerobically grown cells, the 
activity of TMAO reductase was reported to be largely reduced down to 5% as compared to 
anaerobically grown cells.8 Here, a postranslational inactivation has to occur, since the protein 
levels were not reduced under aerobic conditions. 19 
The E. coli TMAO reductase complex faces the periplasm and consists of the molybdenum 
cofactor (Moco)-containing terminal reductase TorA responsible for substrate-binding/conversion 
and the membrane-associated c-type cytochrome TorC, which uses a menaquinol or 
demethylmenaquinol as electron donor.5, 9, 10 TorA contains the form of Moco typical for the 
dimethylsulfoxide (DMSO) reductase family of molybdoenzymes, which is composed as a bis-
molybdopterin guanine dinucleotide (bis-MGD).11 Enzymes of this family, which are only 
present in prokaryotes, fulfill important physiological functions by playing vital roles in the 
global nitrogen and carbon cycles and in the detoxification of species such as arsenite, selenite or 
chlorate.12 In almost all cases, the enzymes catalyze reactions that involve two-electron 
oxidation-reduction chemistry coupled to the transfer of an oxygen and two protons to form 
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water, or the reverse reaction.13  
DMSO reductase family enzymes were revealed to display a diverse coordination environment at 
the molybdenum atom.14 In enzymes like e.g. nitrate reductase, DMSO reductase or formate 
dehydrogenase (FDH) the molybdenum coordination sphere encompasses the four sulfur atoms 
from the two dithiolene groups of the pyranopterin rings and further an oxo- or sulfido group as 
fifth ligand and a sixth ligand usually represented by an amino acid from the protein backbone 
being a serine, a cysteine, a selenocysteine, or an aspartate.15-18 However, a hydroxide and/or 
water molecule has also been identified to be present in arsenite oxidase.12, 19 The X-ray 
absorption fine structure data of TorA resulted in the interpretation of the molybdenum 
coordination sphere of TorA containing four dithiolene sulfur ligands, one serine-oxygen ligand 
and a oxo-/hydroxo-/water-ligand or oxygen atom.20  
Since expression studies showed that the protein levels of TorA remained constant during aerobic 
and anaerobic growth while enzyme activity was reduced down to 5%, we investigated the effect 
of oxygen on TorA activity in more detail.8, 21 Here, we show that under anaerobic conditions the 
molybdenum coordination environment of TorA contains a sulfido ligand, which is lost during 
aerobic purification of the enzyme. In particular, by in vitro reconstitution of apo-TorA with 
Moco's from different sources we showed that higher activities of TorA were gained when a 
terminal sulfido ligand was present at the cofactor. Investigations by direct electrochemistry 
showed a catalytic current only with sulfido-ligand containing TorA enzyme variants. 
Furthermore, we were able to isolate and insert functional bis-MGD into apo-TorA to yield active 
enzyme, extracted from Mo=S/bis-MGD containing FDH as source enzyme. By substituting the 
active site serine 191 to a cysteine in combination with alkylation of this introduced amino acid, 
we demonstrated that the cysteine is not required as a ligand to the molybdenum atom during 
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catalysis. The combination of the results of this study led us to propose a Mo coordination sphere 
of TorA in which a sulfido- rather than an oxo-ligand is present, resulting in a novel model for 
substrate binding.  
 
EXPERIMENTAL PROCEDURES 
Expression and Purification conditions. 
Apo-TorA (from pJF119EH22), MobA (from pCT800A23), and TorD (from pET28TorD22) were 
expressed and purified as described previously with slight modifications. Site directed 
mutagenesis of TorA was performed using the Agilent QuikChangeLightning Kit. Moco-
containing TorA wild type and TorA-S191C were expressed in E. coli BW25113 cells. For 
expression under aerobic conditions, the main culture was inoculated with aerobically grown 
preculture (12h, 37°C and 220 rpm) in a 1:500 dilution. The main culture was supplemented with 
20 µM isopropyl b-D-1-thiogalactopyranoside (IPTG) and ampicillin (150 µg/mL) and grown for 
24h at 30°C and 130 rpm under aerobic conditions. For expression under anaerobic conditions, 
precultures were supplemented with ampicillin (150 µg/mL) and grown aerobically (12h, 37°C 
and 220 rpm). The main culture was inoculated with preculture in a 1:10 dilution and 
supplemented with 70 µM IPTG, 1 mM molybdate, ampicillin (150 µg/mL) and 7 mM TMAO. 
For anaerobic expression, cultures were grown in closed flasks at 37°C for 30h. Expression of 
XDH or XDHdesulfo(ΔXdhC) was carried out as described previously.24, 25  
After harvesting of cells and cell lysis, the cleared lysate was applied to 0.3-0.5 mL of Ni-
nitrilotriacetate (Ni-NTA, Macherey & Nagel, Düren, Germany) resin per Liter of cell culture, 
depending on the growth conditions. For purification of anaerobically expressed TMAO 
reductase under aerobic conditions (-O2ex/+O2pur) 0.3 mL of Ni-NTA per liter of E. coli was used. 
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The loaded resin was washed with 20 column volumes of 50 mM NaH2PO4 buffer, 10 mM and 
20 mM imidazole each. Elution of the proteins was achieved with buffer containing 250 mM 
imidazole. For purification of anaerobically expressed TMAO reductase, cells of anaerobic 
cultures were split into two fractions after harvesting. One fraction was subjected to aerobic 
purification (-O2ex/+O2pur) as described above and the other fraction was transferred into the glove 
box (Coy Laboratory Products, Grass Lake, MI) and allowed to rest for at least 2h to become 
anaerobic (-O2ex/-O2pur). Cell lysis was carried out by sonication (HUT SONI130, G. Heinemann, 
Schwäbisch Gmünd, Germany) followed by Ni-NTA chromatography including all purification-
steps described for aerobic purification.  
R. capsulatus FDH and XDH were purified as described previously.25, 26 Proteins were 
transferred into storage buffer using PD-10 columns (GE Healthcare, Piscataway, NJ). All 
proteins except for FDH were stored in Tris-HCl, pH 7.2. FDH was stored in 75 mM potassium 
phosphate, 10 mM azide, pH 7.5. 
 
Cofactor analysis. 
Metal analysis was performed using PerkinElmer (Waltham, MA) Life Sciences Optima 2100DV 
inductively coupled plasma optical emission spectrometer as described earlier.27 The bis-MGD 
cofactor was detected fluorometrically after its conversion to FormA-GMP with slight 
modifications.28 200 µL of pure protein solution (5 to 10 µM) in 100 mM Tris-HCl, pH 7.2 were 
oxidized by the addition of 25 µL acidic iodine and incubated over night at room temperature. 
Excess of iodine was removed by addition of 27.5 µL 1% ascorbic acid and pH was adjusted to 
8.3 by addition of 100 µL 1M Tris. Separation of the FormA-GMP fraction was carried out using 
a C18 reversed phase HPLC column (4.6 * 250 mm ODS Hypersil (Thermo Fisher, particle size 
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5 µm) equilibrated in 5 mM ammonium acetate and 15% (v/v) methanol. Detection of FormA-
GMP during elution was carried out using an Agilent 1100 series fluorescence detector 
(excitation at 383 nm, emission at 450 nm). 
 
Enzyme assays. 
TMAO reductase activity was measured under anaerobic conditions in a volume of 1 mL 
following the oxidation of pre-reduced benzyl viologen at 600 nm. The activity assay contained 
40 mM benzyl viologen and 7.5 mM TMAO as substrate in 100 mM Sorenson’s phosphate 
buffer, pH 6.5. Benzyl viologen reduction was achieved by addition of sodium dithionite until 
OD600 nm=1 was reached. Measurement was started by addition of 0.2 µg to 2 µg of TorA. The 
activity was calculated using the equation U = 0.5 x (∆Abs600/min)/ε600(benzyl viologen)/V, 
using the extinction coefficient for benzyl viologen of 7.4 mmol-1 x cm-1. One Unit is defined as 
the reduction of 1 µmol TMAO per minute. 
 
Apo-TorA reconstitution assays. 
For in vitro apo-TorA reconstitution, R. capsulatus XDH wild type or XDH expressed in the 
absence of XdhC (XDHdesulfo(ΔXdhC)) was used as Moco source. For Moco extraction from these 
enzymes, 30 µM of proteins were incubated at 95 °C for 4 minutes in a total volume of 400 µL. 
After centrifugation, the supernatant was used as Moco source. Reconstitution mixtures were 
incubated at 37 °C for 7 h and contained 1.3 µM apo-TorA, 2 µM TorD, 2 µM MobA, 1 mM 
5'GTP and 1 mM MgCl2 and 200 µL Moco-containing supernatant in 100 mM Tris-HCl, pH 7.2. 
For apo-TorA reconstitution with Moco extracted from R. capsulatus FDH (sulfido-containing 
bis-MGD), 1.3 µM apo-TorA were mixed with 200 µL supernatant of 30 µM heat denatured 
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FDH in 100 mM Tris-HCl, pH 7.2. The reconstitution assay was incubated at 37 °C for 7 h. All 
steps of Moco extraction and TorA reconstitution were carried out under anoxic conditions in a 
glove box (Coy Laboratory Products, Grass Lake, MI). After incubation, reconstituted TorA was 
purified from the mixtures by gel filtration on a Superdex200 10/300GL column (GE 
Healthcare). TorA containing fractions were combined and used for further assays.  
 
Cyanide treatment and chemical sulfuration of proteins. 
Desulfuration of XDH was achieved after incubation with 10 mM potassium cyanide for at least 
3h at room temperature. Released thiocyanate was removed by gel filtration using PD-10 
columns (GE Healthcare). For chemical sulfuration of XDH, 1 mL of protein was treated under 
anaerobic conditions with 10 µL of 2.5 mM methyl viologen, 20 µL of 100 mM Na2S and sodium 
dithionite until a slight blue color of the solution appeared due to reduction of methyl viologen. 
The sulfuration assay was incubated at room temperature for 30 minutes. Afterwards XDH was 
desalted using PD-10 columns (GE Healthcare).  
 
Carboxamidomethylation of TorA and TorA-S191C.  
TorA and TorA-S191C samples (5.04 µM in 100 mM, pH 7.2) were incubated with 1 mM 
iodoacetamide (IAA) in the presence or absence of 7.5 mM TMAO for 150 minutes in a total 
volume of 500 µL. Afterwards all samples were applied to gel filtration (Nick columns, GE 
Healthcare) to remove unbound TMAO and/or IAA. Control proteins were treated with the same 
volume of 100 mM Tris-HCl buffer instead of TMAO or IAA. The eluted proteins were 
concentrated using ultracentrifugation devices (Amicon Ultra, 10 kDa cutoff) to a final volume of 
50 µL. The concentrated samples were applied to denaturing SDS-PAGE (16 µg protein per 
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lane). After Coomassie staining, gel bands corresponding to TorA were cut and dried using the 
vacuum centrifuge for 45 minutes at 37 °C. 
 
LC-MS/MS. 
After SDS-PAGE gel pieces containing the TorA subunit were reduced using 50 µL of 50 mM 
TCEP for 1 h at 60 °C followed by alkylation with 30 µL of 200 mM methyl 
methanethiosulfonate (MMTS) for 10 minutes at RT, and in-gel digestion with trypsin overnight 
at 37 °C (Promega, USA). Obtained peptides were extracted and purified with reversed-phase 
C18 ZipTips (Millipore, USA). LC-MS/MS analyses of desalted peptides were performed on a 
Dionex UltiMate 3000 n-RSLC system connected to an Orbitrap FusionTM TribridTM MS 
(Thermo Scientific, Dreieich, Germany). Peptides were loaded onto a C18 pre-column (3 µm 
RP18 beads, Acclaim, 75 µm x 20 mm), washed for 3 minutes at a flow rate of 6 µL/min and 
separated on a C18 analytical column (3-µm, Acclaim PepMap RSLC, 75 µm x 50 cm, Dionex) at 
a flow rate of 200 nL/min via a linear 60 minute gradient from 97% buffer A (buffer A = 0.1% 
formic acid in water) to 25% B (buffer B = 0.1% formic acid in 80% acetonitrile), followed by a 
15 minute gradient from 25% buffer B to 62% buffer B. The effluent was electro-sprayed by a 
stainless steel emitter (Thermo Scientific). The mass spectrometer was controlled and operated in 
the data-dependent mode using the Xcalibur software allowing the automatic selection of 2-4 fold 
charged peptides and their subsequent fragmentation (top speed mode) using the ion routing 
multipole with nitrogen as collision gas (HCD) and orbitrap detection (resolution 15 K). Every 3 
seconds a MS survey scan was performed (resolution 120 K). The maximum collection time for 
peptides was set to 200 ms. Dynamic exclusion was set to 6 seconds.  MS/MS raw data files were 
processed via the Proteome Discoverer program Version 1.4 (Thermo Scientific) on a Mascot 
	 11	
server (V. 2.3.02, Matrix Science) using the NCBI database. The following search parameters 
were used: enzyme, trypsin; maximum missed cleavages: 1, variable modifications: methyl 
methanethiosulfonate MMTS (C) and carboxamidomethyl CAM (C); peptide tolerance, 10 ppm; 
MS/MS tolerance, 0.03 Da. For relative quantification of peptides of interest, ion traces of the 
respective molecular ions with a mass tolerance of 10 ppm were used. 
 
Electrochemistry. 
The electrochemical experiments were carried out in a lab-built three-electrode cell with a total 
volume of 1 mL, employing a platinum wire as counter electrode, an Ag/AgCl, 1 M KCl 
reference electrode (Microelectrodes Inc.; Bedford, NH, USA) against which all potentials are 
reported, and a modified graphite rod working electrode (Alfa Aesar; Karlsruhe, Germany). All 
the experiments were performed at room temperature in a glovebox under anaerobic conditions 
(minimum of 2% H2 and 98% N2) with PalmSens potentiostat and analyzed with PSLite 4.8 
software (Pamlsens, The Netherlands) and OriginPro 2016. 
 
Electrode modification. 
A graphite rod electrode with a diameter of 3.5 mm was cleaned on emery paper with two 
different grain sizes and afterwards ultrasonicated for 20 s and dried under N2 stream. The 
cleaned electrode was modified with a mixture of 1:1 volume ratio of 2 mM 
didodecyldimethylammonium bromide (DDAB) and TorA variants. For the direct 
bioelectrocatalysis different concentrations of TorA were used, dependent on the Moco saturation 
in the enzyme. A 6 µL aliquot of this mixture was drop-casted on the electrode surface and left to 
dry in a desiccator at 4 °C for 15-20 minutes. The electrode was then transferred to the anaerobic 
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glovebox and used for the experiments. The measurements of the bioelectrocatalysis were always 
performed under conditions of saturated substrate concentration and constant stirring of the cell 
solution to prevent substrate-limited conditions.  
The mediated electrochemistry was performed in the presence of 1 mM methyl viologen as a 
mediator and the modification and substrate concentration were kept the same as for the 
unmediated electrochemistry. During the modification, the concentration of the enzyme variants 
applied to the electrode surface was kept constant (290 µM). Chronoamperometry was performed 
at Eapplied = -0.8 V. The value of the catalytic current was measured as difference of the stationary 
currents of the I/t-curve  before and after addition of TMAO.  The onset potential was deduced 
from CV trace where the current rises over the background charging current. 
 
EPR Preparative and Spectroscopic Methods. 
EPR samples were prepared either aerobically in an ice bath or anaerobically in a Coy Chamber 
at O2 levels < 10 ppm at 4 °C in a thermoblock, in 100 mM Tris, pH 7.2. Typical sample 
preparation methods involved excess addition of freshly-prepared sodium dithionite (10 mM) or 
potassium ferricyanide (10 mM) to as-isolated (non-reconstituted) or as-obtained (reconstituted) 
TorA samples (100 µM) that were then immediately frozen in a liquid nitrogen-cooled ethanol 
bath before complete freezing in liquid nitrogen. Where applicable, as-isolated and as-obtained 
samples were prepared by simple buffer dilution of the enzyme, followed by sample freezing.  
Redox-cycled TorA-WT samples were prepared analogously to the methods reported previously 
for TMAO reductase, as part of purification methods with minor procedural alterations.20, 29  
CW X-Band EPR spectra recorded at 9.4 GHz were obtained using a home-built spectrometer 
(microwave bridge, ER041MR, Bruker, Rheinstetten, Germany; lock-in amplifier, SR810, 
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Stanford Research Systems, Stanford, CA, USA; microwave counter, 53181A, Agilent 
Technologies) equipped with a Bruker SHQ resonator. An ESR 910 helium flow cryostat with an 
ITC503 temperature controller (Oxford Instruments, Oxfordshire, UK) was used for temperature 
control. CuEDTA was used as a standard reference with respect to spin quantitation. Field 
corrections  were performed as needed by measuring a standard solution of sodium dithionite-
reduced sample of R. capsulatus formate dehydrogenase26 (100 µM) at 80 K under acquisition 
conditions identical to those reported herein, and correcting with respect to the [2Fe-2S] clusters 
present. At this temperature, the [2Fe-2S] clusters present are nearly identical to those reported 
for C. necator formate dehydrogenase30. Baseline subtraction was performed relative to a buffer 
blank at the reported temperature. Spin quantitation was performed using the utility 
‘spincounting’ (http://lcts.github.io/spincounting/) in Matlab (Mathworks; Natick, MA, USA) 
with associated tune pictures that measured the sample Q-factor. CuEDTA standards of known 
concentration that were ran on the same day of measurement to estimate the associated 
spectrometer transfer-factor. Simulation of EPR data, where applicable was performed with the 
EasySpin toolbox31 in Matlab and yielded the g-values and associated parameters reported. 
 
RESULTS 
Comparison of aerobically and anaerobically expressed TorA suggests the presence of a sulfido 
ligand in the Mo coordination sphere.  
To investigate the effect of oxygen on the assembly of TorA, we recombinantly expressed  torAD 
under aerobic (+O2ex) and anaerobic (-O2ex) conditions in the presence of 7 mM TMAO and 
characterized the enzymes that were purified either under aerobic (+O2pur) or anaerobic (-O2pur) 




Figure 1: The effect of oxygen on the TMAO reductase activity of TorA.  
TorA was expressed and purified either aerobically (+O2) or anaerobically (-O2), respectively, as 
described under Materials and Methods. (A) Specific activity of TorA at 30°C in U/mg (µmol of 
TMAO reduced per minute and mg of enzyme). (B) Relative FormA-GMP fluorescence of bis-
MGD released from TorA. The bis-MGD cofactor was oxidized to FormA-GMP and quantified 
after separation on a C18-RP column. Integrated FormA-GMP peak-areas were related to the 
amount of protein in mg. (C) Relative TMAO reductase activities (U/MGD) in µmol TMAO 
reduced per MGD present in the protein (calculated as specific activities (U/mg) shown in panel 
A divided by relative fluorescence values in (LU/mg) in panel B). 
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The specific activity of the aerobically expressed and purified (+O2ex/+O2pur) enzyme was largely 
reduced to 5% compared to the anaerobically expressed and purified (-O2ex/-O2pur) enzyme 
(Figure 1A). The reduced activity can only be partially explained by a reduced bis-MGD content, 
since the detected MGD (as FormA-GMP) was 30% relative to the completely anaerobically 
prepared sample (Figure 1B). We related the enzyme activity to the amount of FormA-GMP 
detected in the enzyme instead to using the molybdenum content, since we observed unspecific 
molybdate binding to TorA preparations. Since also unspecific GMP binding was observed, 
detected FormA-GMP should refer only to specifically bound bis-MGD to the enzyme.32-34 The 
aerobically prepared sample showed 20% of the activity/bis-MGD as detected for the 
anaerobically prepared enzyme (Figure 1C). Surprisingly, when the anaerobically expressed 
enzyme was purified under aerobic conditions (-O2ex/+O2pur), a similar loss of activity in addition 
to a reduced MGD content was observed (Figure 1A + B). When relating the specific activity to 
the MGD content, the aerobically purified enzyme (-O2ex/+O2pur) had a reduced relative activity 
of 25% as compared to the enzyme purified under anaerobic conditions (-O2ex/-O2pur) (Figure 
1C), showing an inactivation of the enzyme by oxygen. 
To determine the basis of the differences in activity in the aerobically and anaerobically prepared 
enzymes, we analyzed the impact of different ligands at the Mo coordination sphere on TorA 
activity. Here, we made use of the established in vitro reconstitution system for apo-TorA with in 
vitro synthesized bis-MGD, which enabled us to use different forms of Mo-MPT as initial 
cofactor source.33 The bis-MGD free form of TorA can be obtained from a Moco-deficient E. coli 
strain (see experimental procedures). This assay solely consists of purified MobA, Mg-GTP and 
extracted Moco from an enzyme source (i.e. xanthine dehydrogenase (XDH) or sulfite oxidase) in 
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addition to apo-TorA and TorD.33, 35 While the reconstitution of TorA is performed under 
anaerobic conditions, TorA is subsequently purified from the reconstitution mixture under 
aerobic conditions, so that the obtained activities of the reconstituted enzymes consequently were 
compared to the activities of the TorA-WT (-O2ex/-O2pur) enzyme (which was set to 100% activity 
in Figure 2 for better comparability).  
	 17	
 
Figure 2: The activity of TorA after reconstitution with different cofactors.  
(A) Relative activities of TorA-WT or reconstituted apo-TorA with different cofactors at 30°C in 
U/mg (µmol of TMAO reduced per minute and mg of enzyme). The activities were normalized to 
anaerobically expressed and aerobically purified TorA-WT (-O2ex/+O2pur) (shown in Figure 1) set 
to an activity of 100%. Reconstitution of 1.3 µM apo-TorA was carried out under anaerobic 
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conditions by incubation with 2 µM MobA, 200 µl of the respective isolated Mo-MPT forms in 
the presence of 1 mM GTP, 1 mM MgCl2, and 2 µM TorD. Gel filtration was performed under 
aerobic conditions to separate TorA from the reconstitution mixture. (B) Relative FormA-GMP 
fluorescence of bis-MGD released from TorA. The bis-MGD cofactor was oxidized to FormA-
GMP and quantified after separation on a C18-RP column. Integrated FormA-GMP peak-areas 
were related to the amount of protein in mg. Relative FormA-GMP fluorescence (LU*s/mg) was 
normalized to anaerobically expressed and aerobically purified TorA-WT set to 100%. (C) 
Relative TMAO reductase activities (U/MGD) in µmol TMAO reduced per MGD present in the 
protein (calculated as relative activities (U/mg) shown in panel A divided by relative fluorescence 
values in (LU/mg) in panel B). The obtained values were normalized to anaerobically expressed 
and aerobically purified TorA-WT (-O2ex/+O2pur) set to 100%. 
 
To study the influence of a sulfur ligand in the Mo coordination sphere on TorA activity, we 
extracted the sulfido-containing Moco from Rhodobacter capsulatus XDH, which can be 
produced in a 100%-loaded form with the Mo=S ligand.36, 37 Using this Mo=S containing Moco, 
the TorA activities showed a saturation of reconstitution after about 5 h (data not shown), 
consistent with the data reported before using sulfite oxidase as Moco source.33 When the source 
XDH contained an oxo ligand in place of the sulfido ligand, which was removed by treatment 
with KCN prior to reconstitution, a reduced relative TorA activity was obtained (Figure 2A-C). 
To assess whether the impaired activity is indeed based on the sulfido ligand, the inactive 
cyanide-treated desulfo XDH was chemically resulfurated.38 The results in Figure 2C show that 
TorA activities were obtained with a comparable activity to the untreated XDH. Further, the 
obtained activities after 7 h of reconstitution were related to their determined relative MGD 
contents. The results in Figure 2C show that the highest relative activity per MGD was obtained 
for reconstituted TorA with native XDH containing the sulfido ligand as Moco source.  
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To verify these results, we used an additional XDH as unsulfurated Mo=O source that was 
expressed in the absence of XdhC (referred to as oxoMocoXDH/∆XdhC), known to be the chaperone 
essential for Moco sulfuration.39 TorA reconstituted with Moco extracted from this enzyme 
resulted in an almost inactive enzyme (Figure 2). When the Moco of XDHΔXdhC was chemically 
sulfurated before extraction, TorA activity was regained. In contrast, when the chemically 
sulfurated Moco from XDHΔXdhC was treated with cyanide, a TorA activity similar to the one 
reconstituted with non-sulfurated XDHΔXdhC was obtained (Figure 2).  
The results overall indicate that TorA activity depends on the presence of a sulfido ligand at the 
bis-MGD cofactor. The presence of the sulfido ligand thereby is influenced when oxygen is 
present during purification. 
 
Reconstitution of TorA with isolated bis-MGD cofactor. 
A coordination sphere with a sulfido ligand at the molybdenum atom has been reported also for 
other molybdoenzymes from the DMSO reductase family like nitrate reductase or FDH15, 16 40. 
For the first time, a direct reconstitution approach was attempted of an enzyme with an extracted 
bis-MGD cofactor from an enzyme source. Here, we were using Rhodobacter capsulatus FDH 
(RcFDH) as bis-MGD source enzyme, in which the extracted cofactor after heat denaturation was 




Figure 3. The activity of TorA after reconstitution with sulfido-containing bis-MGD 
cofactor extracted from FDH. 
(A) The activity of reconstituted TorA with extracted sulfido-containing bis-MGD from R. 
capsulatus FDH. Extracted bis-MGD was incubated under anaerobic conditions for 0, 30, 90 or 
120 minutes as indicated before the addition of apo-TorA. The activities were normalized to 
anaerobically expressed and aerobically purified TorA-WT (-O2ex/+O2pur) (shown in Figure 1) set 
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to an activity of 100%. (B) Relative FormA-GMP fluorescence of bis-MGD released from TorA 
after reconstitution. The bis-MGD cofactor was oxidized to FormA-GMP and quantified after 
separation on a C18-RP column. Integrated FormA-GMP peak-areas were related to the amount 
of protein in mg. Relative FormA-GMP fluorescence (LU*s/mg) was normalized to anaerobically 
expressed and aerobically purified TorA-WT set to 100%. (C) Relative TMAO reductase 
activities (U/MGD) in µmol TMAO reduced per MGD present in the protein (calculated as 
relative activities (U/mg) shown in panel A divided by relative fluorescence values in (LU/mg) in 
panel B). The obtained values were normalized to anaerobically expressed and aerobically 
purified TorA-WT set to 100%. 
 
With this direct reconstitution procedure active TorA was obtained, showing for the first time 
that the bis-MGD cofactor remained intact outside of the protein. Analysis of the stability of 
extracted bis-MGD showed that the cofactor was stable for 90 minutes after extraction under 
anaerobic conditions, before a decrease in reconstitution efficiency was observed (Figure 3). 
Overall, comparable normalized relative activities of bis-MGD reconstituted TorA were obtained 
as compared to purified TorA-WT (-O2ex/+O2pur) (Figure 3C). 
 
The S191C variant of E. coli TMAO reductase performs TMAO reduction. 
The crystal structure of Shewanella massilia TMAO reductase has revealed a serine residue from 
the protein backbone as a ligand to the molybdenum in TorA.11 Since R. capsulatus FDH40 and 
the E. coli nitrate reductase NapA15 likewise contain an active site cysteine ligand, we set out to 
analyze the influence of the Mo-ligating serine-to-cysteine substitution of the anaerobically 
expressed TorA-S191C variant.  
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Figure 4: Activities of the TorA-S191C variant expressed under aerobic and anaerobic 
conditions.  
(A) Relative activities of TorA-WT in comparison to the TorA-S191C variant at 30°C in U/mg 
(µmol of TMAO reduced per minute and mg of enzyme). The activities were normalized to 
anaerobically expressed and aerobically purified TorA-WT (-O2ex/+O2pur) (shown in Figure 1) set 
to an activity of 100%. (B) Relative FormA-GMP fluorescence of bis-MGD released from TorA 
after reconstitution. The bis-MGD cofactor was oxidized to FormA-GMP and quantified after 
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separation on a C18-RP column. Integrated FormA-GMP peak-areas were related to the amount 
of protein in mg. Relative FormA-GMP fluorescence (LU*s/mg) was normalized to anaerobically 
expressed and aerobically purified TorA-WT set to 100%. (C) Relative TMAO reductase 
activities in µmol TMAO reduced per MGD present in the protein. The obtained values were 
normalized to anaerobically expressed and aerobically purified TorA-WT set to 100%. 
 
As shown in Figure 4, the TorA-S191C (-O2ex/+O2pur) variant was active with a relative activity 
of 38% of TorA-WT expressed under identical expression and purification conditions. The amino 
acid exchange had no influence on the bis-MGD insertion into the enzyme, however, when the 
activity was related to the bis-MGD content, TorA-S191C expressed under anaerobic conditions 
showed only 40% of the activity as compared to anaerobically expressed TorA-WT (Figure 4A-
C). Surprisingly, the TorA-S191C variant expressed and purified under aerobic conditions 
(+O2ex/+O2pur) was as active as the corresponding wild-type protein prepared under the same 
conditions (Figure 4 C). 
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Figure 5: Influence of iodoacetamide on the active-site cysteine in the TorA-S191C variant.  
(A) 5 µM of TorA-WT or TorA-S191C were incubated with either 1 mM IAA, 7.5 mM or 
TMAO as indicated in a total volume of 500 µl for 2.5 hours at room temperature. Afterwards 
unbound reagents were removed using Nick columns (GE). Relative activities of IAA-treated 
TorA-WT and variant TorA-S191C at 30°C in U/mg (µmol of TMAO reduced per minute and 
mg of enzyme). The activities were normalized to anaerobically expressed and aerobically 
purified TorA-WT (-O2ex/+O2pur) (shown in Figure 1) set to an activity of 100%. (B) Relative 
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FormA-GMP fluorescence of bis-MGD released from TorA after reconstitution. The bis-MGD 
cofactor was oxidized to FormA-GMP and quantified after separation on a C18-RP column. 
Integrated FormA-GMP peak-areas were related to the amount of protein in mg. Relative FormA-
GMP fluorescence (LU*s/mg) was normalized to anaerobically expressed and aerobically 
purified TorA-WT set to 100%. (C) Relative TMAO reductase activities (U/MGD) in µmol 
TMAO reduced per MGD present in the protein (calculated as relative activities (U/mg) shown in 
panel A divided by relative fluorescence values in (LU/mg) in panel B). The obtained values 
were normalized to anaerobically expressed and aerobically purified TorA-WT set to 100%. 
 
To analyze whether the cysteine is able to coordinate to the molybdenum ion as a ligand, we 
treated the TorA variant with iodoacetamide. The results in Figure 5 show that the TorA-WT 
activity was not influenced by the presence of iodoacetamide. Further, also the TorA-S191C 
variant showed no loss of activity upon iodoacetamide treatment. HPLC-ESI mass spectrometry 
analysis of the iodoacetamide treated TorA-S191C variant in the presence or absence of TMAO 
revealed a carboxamidomethylation of residue Cys191 (Figure 6). Since the 
carboxamidomethylation in the presence of TMAO reached almost 70%, while the enzyme 
activity was not influenced by the alkylation of the Cys residue, this clearly demonstrates that the 
cysteine is not a ligand to the molybdenum atom and that its contribution is additionally not 





Figure 6. Carboxamidomethylation of TorA-S191C by iodoacetamide. HPLC-ESI-MS 
comparison of the tryptic peptides containing the active site cysteine of the TorA-S191C variant. 
Depicted are the ion traces of the triply charged molecular ions of the carboxamidomethylated 
(m/z = 866.776) and thiomethylated (m/z = 863.098) peptides allowing an approximate 
determination of their relative abundances. Thiomethylation was applied to inhibit disulfide 
bridge formation. The amino acid sequences of the respective peptides were verified by 
additional MS/MS spectra of all relevant ions (data not shown). (A) Carboxamidomethylated 
tryptic TorA-S191C peptide modified by iodoactamide, (B) thiomethylated analogous peptide 
treated with methyl methanethiosulfonate, (C) carboxamidomethylated peptide modified with 
iodoactamide in the presence of TMAO, (D) thiomethylated TorA-S191C treated with methyl 




Electrocatalytic onset potentials of TorA variants determined by direct protein-electrochemistry. 
In order to determine the differences in the reduction potential derived by the presence of a 
sulfido ligand in the coordination sphere of TorA, we determined the onset potentials by protein-
electrochemistry. After the modification of the electrode with enzyme, the electrode was 
immersed in the electrochemical cell and cyclic voltammetry (CV) was performed. The potential 
was cycled between 0 V and -0.7 V or -0.2 and -0.8 V dependent on the TorA variants and 
turnover currents were measured in the presence of TMAO without an additional electron 
acceptor. As shown in Table 1, only the anaerobically expressed TorA-WT, and the reconstituted 
TorA variants (recTorA), recTorAsulfidoMocoXDH, recTorAsulfidobis-MGDFDH, or TorA-S191C 
were catalytically active by direct electrochemistry, while the other variants were inactive. Figure 
7 presents the voltammograms recorded for the anaerobically expressed wild type enzyme, which 




Figure 7: Direct bioelectrocatalysis of immobilized TorA-WT with TMAO as substrate.  
(A) Cyclic voltammograms of TorA-WT anaerobically expressed and aerobically purified (-
O2ex/+O2pur) and (B) TorA-WT anaerobically expressed and anaerobically purified (-O2ex/-O2pur). 
The black traces show the voltammogram recorded when no substrate is present and red traces 
measured in the presence of 3 mM TMAO in the measuring cell. The arrow points at the onset of 
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the catalytic current rise. Conditions: pH 6.5 10 mM phosphate buffer, 3 mM TMAO, scan rate 5 
mV/s, under stirring conditions.  
 
Both variants were also revealed to be active in solution with reduced methyl viologen as electron 
donor. After the addition of TMAO as substrate, the electrocatalytic reduction current emerged 
with a disappearance of the oxidative wave and boost of the cathodic current. The potential at 
which the electrocatalytic current starts to be observable, which is larger than the background 
current without substrate, is called onset potential (Eonset).41 It is marked with a grey arrow in the 
graph of Figure 7 and a clear deviation can be seen in the Eonset between the two different TorA-
WT enzymes. The Eonset at -0.23 V (Figure 7A) and -0.42 V (Figure 7B) indicate the starting 
point of the oxidation of Moco. By increase of the reduction potential, the catalytic current 
increased further until a limiting current was reached and was much more pronounced for the 
fully anaerobically produced TorA-WT (Figure 7B). The data in Table 1 show that direct 
electrocatalytic currents were only obtained for TorA variants which are expected to have a 
sulfido ligand at the Mo atom (see also supplementary Figure S1). All variants reconstituted with 
a Mo=O containing Moco instead did not generate an electrocatalytic response, thus, they are 
considered as being electrochemically inactive (Table 1). Figure S2 shows the blank reaction 
without enzyme while Figure S3 shows the cyclic voltammogramm (CV) for the 
electrocatalytically inactive TorA-WT (+O2ex/+O2pur) for comparison. It is obvious that substrate 
addition did not effect the CV wave in the blank experiments while it clearly increased the 
reduction wave for the catalytic reaction with active enzyme. For the anaerobically expressed and 
aerobically purified TorA-WT enzyme (-O2ex/+O2pur) the Eonset already starts around -0.23 V 
(Figure 7A). Since an Eonset of -0.23 V was obtained in comparison to a more negative Eonset of -
0.42 V obtained for the anaerobically expressed and anaerobically purified TorA-WT (-O2ex/-
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O2pur) and the variants recTorAsulfidoMocoXDH and recTorAsulfidobis-MGDFDH (see also Figure S1) 
which were reconstituted with a sulfido-containing bis-MGD, it can be concluded that a 
decreased exposure of the enzyme to oxygen results in a more negative potential of the Moco. 
Small differences are also present for the TorA-S191C variant (see supplemental Figure S1), 
where the cysteine might have an additional effect on the redox potential of the Moco, even 
though it is not directly coordinated to the molybdenum ion (as shown in Figure 6).  
Since in the solution assays with reduced benzyl viologen as electron donor, TorA activities were 
detected for the variants containing an oxo ligand at the active site, we additionally detected the 
catalytic currents after addition of methyl viologen in an amperometric experiment at -0.8 V. 
Figures S4 and S5 are representative examples of the current trace recorded with an enzyme 
loaded and an enzyme free (blank) electrode. The results in Table 1 show that with the mediator 
methyl viologen, bioelectrocatalysis was detected in the presence of TMAO for all enzyme 
variants. The results are generally comparable among each other. Conclusively, the mediator 
methyl viologen seems to influence the reactivity of TorA on the electrode so that activity can be 
measured independent on the presence of an oxo or sulfido ligand. The same might be true for the 
solution assays where reduced benzyl viologen was used to reduce the enzyme. Thus, in inactive 
TorA protein variants containing an oxo ligand, enzyme activity might have been observed due to 
an artificial activating effect of methyl viologen in the assay.   
 
EPR characterization of aerobically and anaerobically expressed TorA. 
For the first time, TorA was characterized by EPR spectroscopy. Here, our goal was to 
differentiate the sulfido-containing bis-MGD cofactor from the oxo-containing bis-MGD form. 
Consistent with the activity data (Figure 1), differences in the Mo(V) signals were observed for 
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samples expressed under anaerobic versus aerobic conditions under selected redox conditions 
(Figure 8, see also Figure S6 and Table S1).    
 
Figure 8: X-Band Electron Paramagnetic Resonance Redox Profile of TorAWT Samples.  
(A) depicts aerobically expressed and purified TorA (+O2ex/+O2pur), (B) depicts TorA expressed 
anaerobically but purified aerobically (-O2ex/+O2pur), while (C) depicts TorA expressed and 
purified anaerobically (-O2ex/-O2pur). Protein depicted in (C) originated from the same batch of 
anaerobically expressed enzyme. For each panel, the top spectrum depicts the sample as-isolated, 
middle spectrum depicts treatment with 10 mM sodium dithionite, while the bottom spectrum 
depicts treatment with 10 mM Na3Fe(CN)6. Spectra were obtained at 80 K at 3.93 mW 
microwave power, 5 G modulation amplitude and at a 100 kHz modulation frequency. Spectra 
have been scaled to represent a concentration of TorA of 100 µM. 
 
As-isolated samples possessed multiple overlapping species present (Figure 8, top traces; and 
Figure S6), but a more simplified spectrum was observed for the TorA-WT (-O2ex/+O2pur) sample 
(Figure 8A, top trace). Similar to DMSO reductase from R. capsulatus42-44 and arsenite oxidase 
from A. faecalis45, the percent of integrated signal relative to the Mo concentration in the as-
isolated state was low (Table S1), which represented only 3 - 4% of the overall quantity of Mo 
	 32	
present.  Nevertheless, TorA-WT (-O2ex/-O2pur) exhibited largely rhombic signal with g-values of 
1.987, 1.965, and 1.941 (gav = 1.964, g1-g3 = 0.046) (Figure S7). Other spectral components 
detected among as-isolated TorA-WT spectra included two axial signals at 330-333 mT and at 
339-342 mT (Figure 8A top trace, see also Figure S6 top trace); the latter signal could also be 
observed in the TorA-WT (+O2ex/+O2pur) sample (Figure 8B top trace, see also Figure S6 middle 
trace). However, these signals were largely absent in the TorA-WT (-O2ex/-O2pur) spectrum, 
suggesting that the rhombic signal is associated with a sulfurated bis-MGD species (Figure 8B 
and C, top traces; Figure S6, top and middle traces; Figure S7).  
Notable differences in TorA-WT Mo(V) signals were observed upon treatment with redox agents.  
Treatment of TorA-WT samples with either TMA or TMAO resulted in negligible spectral 
changes relative to as-isolated spectra (data not shown). Interestingly, sodium dithionite 
reduction of anaerobically expressed TorA-WT (-O2ex/+O2pur, -O2ex/-O2pur) samples resulted in 
generation of a new signal at higher field (lowered gav) with a spin concentration at least doubled 
relative to as-isolated spectra, respectively. The resultant signal was similar to the low-g type 
species reported for DMSO reductase (Figure 8B + C, middle traces).42, 43 By comparison, very 
minor changes were observed upon exposure to dithionite in the aerobic enzyme (Figure 8A, top 
and middle traces). Oxidative treatment of TorA-WT with ferricyanide resulted in generation of 
an axial signal at 330-336 mT, however, its generation appeared to be independent of sample 
anaerobicity and it predominated the TorA-WT (+O2ex/+O2pur) spectrum (Figure 8A-C, bottom 
spectra). The remaining signal in ferricyanide-oxidized samples were largely similar to as-
isolated signals, with a similar rhombic signal observed in TorA-WT (-O2ex/-O2pur). Collectively, 
these results suggest that the rhombic signal in the as-isolated TorA-WT (-O2ex/-O2pur) spectrum 
is likely associated as a sulfurated bis-MGD species. 
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EPR characterization of in vitro-reconstituted TorA. 
EPR spectral characterization of sulfidoMocoXDH and sulfidobis-MGDFDH was performed to compare 
Mo(V) species associated with bis-MGD sources with a more clearly defined sulfido ligand.   
Similar to the TorA-WT (-O2ex/-O2pur) as-isolated spectrum, a rhombic signal was observed in as-
obtained recTorA sulfidoMocoXDH and recTorA sulfidobis-MGDFDH (Figure 9A).  
 
Figure 9: X-Band EPR Characterization of TorA Variants.   
 (A) and (B) depict as-obtained and dithionite-reduced (10 mM) TorA-WT (top trace), 
recTorAsulfidoMocoXDH (middle trace) and recTorAsulfidoMocoFDH (bottom trace) samples, 
respectively. (C) depicts TorA-WT (top trace) and TorA-S191C (bottom trace) that were 
expressed anaerobically and purified aerobically (-O2ex/+O2pur). The TorA-WT data of (A) and 
(B) represent the TorA-WT data depicted in Figure 8C, and for (C) represents TorA-WT data 
depicted in Figure 8B, respectively. Spectra in all panels have been scaled to represent a 
molybdenum concentration of TorA of 100 µM.  Spectra were obtained at 80 K at 3.93 mW 
microwave power, 5 G modulation amplitude and at a 100 kHz modulation frequency.  
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Simulation of the main signal in the as-obtained recTorA sulfidobis-MGDFDH spectrum yielded a 
component with principal g-values of 1.997, 1.986, and 1.967 (gav = 1.983, g1-g3 = 0.030) (Figure 
S9). This signal is similar to the as-isolated TorA-WT (-O2ex/-O2pur) sample, which had an 
increased gav and a decreased linewidth. By comparison, an additional axial signal at 328-336 mT 
was observed in recTorA sulfidoMocoXDH and recTorA sulfidobis-MGDFDH as a major and minor 
species, respectively (Figure 9A, middle and bottom traces). However, the similarity of the 
simulated rhombic signal here to TorA-WT suggests that it is a common element associated with 
sulfurated bis-MGD. 
Treatment of recTorA sulfidoMocoXDH and recTorA sulfidobis-MGDFDH with sodium dithionite 
resulted in distinct generation of Mo(V) signals relative to the TorA-WT  (Figure 9B). While 
generation of the signal at 343-347 mT in TorA-WT (-O2ex/-O2pur) could be detected in recTorA 
samples, it was by comparison a minor component (Figure 9B, top and bottom traces).  
Conservative changes accompanied dithionite addition to recTorAsulfidobis-MGDFDH, yielding a 
signal similar to the as-obtained spectrum (Figure 9A-B, bottom traces). By comparison, 
dithionite reduction of recTorAsulfidoMocoXDH was more heterogeneous, particularly in the 
introduction of a low field rhombic signal distinct from that in the as-obtained state (Figure 9B, 
middle trace). This signal is similar to a signal reported in R. capsulatus DMSO reductase 
assigned to represent a sulfur-centered pterin radical.44, 46 Thus, these spectral results suggest that 
the different response to dithionite between recTorAsulfidobis-MGDFDH and TorA-WT (-O2ex/-
O2pur) imply an altered homogeneity of the TorA bis-MGD, with the as-obtained signal in 




EPR characterization of the TorA-S191C variant. 
The TorA-S191C variant that was expressed anaerobically and purified aerobically (-O2ex/+O2pur) 
was characterized by EPR spectroscopy to compare the electronic effects of the serine to cysteine 
exchange at the bis-MGD cofactor. Figure 9C (bottom trace) depicts TorA-S191C under as-
isolated conditions. Relative to TorA-WT, the whole spectrum is shifted toward lower field for 
TorA-S191C, resulting in an increased gav. The spin quantification of the as-isolated TorA-S191C 
Mo(V) signal was decreased relative to that observed in TorA-WT (Figure 9C, and Table S1). 
However, the signal appeared to have structure, and qualitatively appeared similar to the R. 
sphaeroides DorA-S147C variant47, with similar overlapping features. The spectrum represents at 
least two discrete species that are distinct from the R. sphaeroides DMSO reductase that have an 
overall higher gav (Figure 9C).47  Following the general trend regarding the number of sulfur 
atoms that is reported to affect the Mo(V) gav48-50, it appears that the serine substitution for 
cysteine resulted in an increased gav.  
 
DISCUSSION 
The reduction of TMAO to TMA by TorA involves two-electron reduction chemistry coupled to 
the transfer of an oxygen atom and two protons to form water.12 The active site of the oxidized 
Mo(VI) enzyme has been suggested previously to be six-coordinated with two pyranopterin 
dithiolene ligands providing four sulfur donors to the metal, one terminal oxo ligand and a 
coordinating serine residue.20 In this report, we present clear evidence that a sulfido ligand is 




Figure 10: Proposed active site structures of TorA.  
(A) Proposed active site structure of TorA containing two dithiolene ligands, one sulfido group, 
and one oxygen group from serine in the oxidized Mo(VI) state. (B) The substrate binds to the 
reduced Mo(IV) and displaces the serine ligand. (C) In the TorA-S191C variant, the cysteine is 
not a ligand to the molybdenum atom. 
 
We started our investigations based on the fact that in E. coli, the TorA protein was shown to be 
present both under aerobic and anaerobic conditions.21 However, the aerobically expressed 
protein proved to be significantly less active with an activity of approximately 5% in comparison 
to the anaerobically expressed enzyme.8 By different corroborative methods, we provide evidence 
that the aerobically expressed enzyme contains the oxo ligand at the active site, while the 
anaerobically expressed enzyme contains a sulfido ligand (Figure 10A). Thus, we conclude from 
our data that the bis-MGD cofactor is damaged during aerobic purification of the enzyme, shown 
by a reduced bis-MGD content of the enzyme, 30% reduced enzyme activities and a more 
heterogeneous EPR Mo(V) spectrum. Additionally, the onset potential in the direct 
electrochemistry of the enzyme on the electrode was shown to be more positive in the aerobically 
purified enzyme, also revealing a modified, likely oxidatively damaged form of the bis-MGD 
cofactor. Therefore, we conclude that during aerobic expression in the cell, the bis-MGD cofactor 
is oxidatively damaged resulting further in the loss of the sulfido ligand. The enzyme directly 
reconstituted with sulfido-containing bis-MGD, instead, showed a high activity and a relatively 
more simplified EPR spectrum. This interpretation is consistent with a previous study on the 
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characterization of E. coli TorA active site by X-ray absorption spectroscopy. In this study, the  
inactive as-isolated enzyme was used, revealing that one dithiolene group of the bis-MGD was 
dissociated from the molybdenum atom which consequently contributed to the  inactivity of the 
enzyme.20 An active form of the enzyme was only obtained after redox cycling with dithionite. 
The X-ray absorption spectroscopy data obtained for the redox-cycled enzyme were interpreted 
to contain a molybdenum coordination environment with four dithiolene-based sulfur atoms, one 
double bonded oxygen ligand and one serine-based oxygen ligand from the protein backbone. In 
contrast to these data, the interpretation of the crystal structure data from S. massilia TMAO 
reductase11 (E. coli and S. massilia TMAO reductases share 49% sequence identity and 67% 
sequence similarities) has suggested a molybdenum coordination sphere with two dithiolene 
sulfur ligands and three oxygen ligands (one from serine). The existing data overall imply that in 
previous studies different forms of TMAO reductase were obtained, due to oxidative damage of 
the cofactor in the enzyme or partial photoreduction during data collection. Similar observations 
have been made for DMSO reductase from R. capsulatus and R. sphaeroides, where three 
different crystal structures were derived showing different Mo species in the active site.17, 51-53 
EPR characterizations of TorA in this study also showed that the active site is 
heterogeneous with respect to identifiable Mo(V) species present. Similar behavior has been 
reported for DMSO reductase42-44 in the quantity and type of species present. Thus, TMAO 
reductase harbors several paramagnetic species that are observable by EPR spectroscopy, which 
are dependent on the method of enzyme handling and show a distinct behavior to different redox 
treatments. A more simplified Mo(V) EPR spectrum could be identified in apo-TorA 
reconstituted with the bis-MGD cofactor extracted from R. capsulatus FDH. Here, our data 
provide first-time evidence that the bis-MGD cofactor can be extracted from molybdoenzymes, 
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and that this cofactor remains intact for at least 90 minutes outside of the protein environment. 
The extracted cofactor was inserted into apo-TorA, which gained comparable activity but higher 
homogeneity in comparison to the enzyme purified under anaerobic conditions from E. coli cells, 
thus, the cofactor extraction and insertion procedures preserves an intact bis-MGD cofactor that 
is inserted with a proper coordinating environment into apo-TorA. Further, the sulfido-ligand 
seems to remain coordinated at the extracted bis-MGD cofactor, as evidenced by the EPR 
spectra. 
Our studies by direct electrochemistry proved that the enzyme showed substrate-dependent 
electrocatalytic activity when the sulfido ligand was present at the active site. Further, a fully 
saturated ligand sphere with the sulfido ligand resulted in the shift of the apparent onset potential 
to the more negative region, resulting in the most negative onset potentials for 
recTorAsulfidoMocoXDH and recTorAsulfidobis-MGDFDH reconstituted enzymes. Likely, the enzyme 
expressed under anaerobic conditions, but purified under aerobic conditions contained a partially 
oxidative damaged cofactor, which resulted in a more positive onset potential. The fact that onset 
potentials in the direct electrochemistry were only obtained when a sulfido ligand was present at 
the molybdenum site and not an oxo ligand may reflect that the sulfido-containing bis-MGD 
adopts a different conformation in the enzyme, resulting in a form that is able to directly 
communicate with the electrode. Furthermore, the sulfur ligand modulates probably the redox 
potentials of the Mo ion into the range required for TMAO reduction. Since the cofactor is deeply 
buried in the enzyme, the cofactor has to move more towards the surface of the substrate-binding 
pocket. This model is consistent with a previous investigation by Rothery, Kirk, Weiner and 
coworkers, who showed a conformational flexibility of the bis-MGD cofactor in dependence on 
its reduction state.54 When mediated electrochemistry was performed with methyl viologen as 
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artificial redox mediator, electrocatalysis was obtained for all enzymes, and was independent of 
the presence or absence of the sulfido ligand in the enzyme. Thus, the artificial electron mediators 
methyl viologen or benzyl viologen used in the electrochemistry or solution assays, respectively, 
seem to modulate the enzyme in a manner that enzymatic activity can be obtained. This might be 
based on an interaction of the mediators with the cofactor, resulting in a similar conformation as 
the sulfido-containing bis-MGD, consequently enabling the communication with the electrode.  
The replacement of the active site serine 191 by a cysteine resulted in a catalytically active 
enzyme and alkylation studies revealed that the cysteine is not a ligand to the Mo atom. A similar 
observation has been recently proposed for R. sphaeroides DMSO reductase, a homologous 
enzyme to TMAO reductase coordinating the bis-MGD cofactor with four dithiolene sulfurs, one 
oxo ligand and a serine ligand in the oxidized state.55 Recent studies by DFT calculations of the 
available crystal structure data and extended X-ray absorption fine structure (EXAFS) studies 
have suggested that the Ser147 in DMSO reductase has more flexibility than previously 
suggested and that it might be able to dissociate from the molybdenum atom.56 Characterization 
of the Mo(V) oxidation state of TorA-S191C by EPR spectroscopy showed relative to TorA-WT 
a shifted spectrum corresponding to a higher gav, suggesting that the ligand imposes electronic 
differences on the bis-MGD and likewise support ligand-molybdenum atom dissociation.  
Overall, we suggest a novel substrate-binding mode of TMAO at the molybdenum site (Figure 
10). With a sulfido ligand in place of the oxo ligand, the Mo(IV/V/VI) is tuned to the appropriate 
redox range for TMAO reduction. The substrate can not bind at the position of the sulfido ligand, 
otherwise the sulfido ligand is lost after one substrate turnover, resulting in an inactive enzyme. 
Therefore, we suggest that the substrate TMAO binds in place of the serine ligand at the active 
site (Figure 10B). This mechanism would be similar to the suggested mechanism of Ralstonia 
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eutropha nitrate reductase and the mechanism suggested for nitrate reduction by R. capsulatus 
FDH.15, 18 The displacement of the serine ligand is supported by the data obtained for the TorA-
S191C variant (Figure 10C), for which a 100% alkylation of the cysteine ligand was shown after 
iodoacetamide treatment, while the protein retained its activity. Thus, at least in the TorA-S191C 
variant, the cysteine is not a ligand to the molybdenum atom and the substrate is proposed to bind 
to the free coordination site at the molybdenum atom.  
Conclusively, it has to be considered also for other enzymes of the DMSO reductase family that a 
sulfido ligand might be present at the molybdenum atom, since TMAO reductase represents the 
third enzyme in addition to nitrate reductase and FDH for which a sulfido ligand has been 
identified.15, 16, 18 Anaerobic expression and purification might be obligatory for conserving the 
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Table S1: TorA sample protein, Mo, and spin concentrations used in EPR spectroscopy.     
Figure S1: Direct bioelectrocatalysis of active TorA variants with TMAO as substrate.  
Figure S2: Cyclic voltammogram of the blank electrode (no enzyme immobilized) in the presence 
and absence of TMAO. 
Figure S3: Direct bioelectrocatalysis of immobilized aerobically expressed and purified TorA-
WT with TMAO as substrate. 
Figure S4: Amperometric curves for mediated bioelectrocatalysis. 
Figure S5: Amperometric curves for the blank electrode. 
Figure S6: Zoomed-in view of as-isolated TorA-WT EPR spectra.   
Figure S7: EPR spectral simulation of TorA-WT (-O2ex/-O2pur) in the as-isolated state. 
Figure S8: EPR spectral simulation of recTorAsulfidobis-MGDFDH in the as-obtained state. 
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Table 1: List of TorA-variants investigated for direct (DET) and mediated (MET) electrocatalysis 
after immobilization and the values for Eonset.  
 




TorA-WT (-O2ex/-O2pur) -0.42 ± 0.03 83.16 ± 3.50 
TorA-WT (-O2ex/+O2pur) -0.23 ± 0.01 63.16 ± 5.26 
TorA-WT (+O2ex/+O2pur) -c 47.18 ± 7.90 
recTorAsulfidoMocoXDH -0.45 ± 0.03 55.20 ± 5.86 
recTorAoxoMocoXDH+KCN - 53.28 ± 2.73 
recTorAoxoMocoXDH/∆XdhC - 17.52 ± 1.47 
recTorAsulfidoMocoXDH/KCN+sulfide - 25.14 ± 2.80 
recTorAsulfidobis-MGDFDH -0.47 ± 0.01 81.99 ± 8.53 
TorA-S191C (-O2ex/+O2pur) -0.43 ± 0.03 30.64 ± 1.96 
TorA-S191C (+O2ex/+O2pur) - 32.05 ± 3.53 
apo-TorA - - 
 
aEonset was determined using CV.  
bMET is determined by measurement of the stationary reduction current after the addition of 3 
mM TMAO to a solution containing 1 mM methyl viologen using  amperometry at -0.8V. 
 c(–) = no activity detected.  
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Figure S1: Direct bioelectrocatalysis of active TorA variants with TMAO as substrate.  
Figure S2: Cyclic voltammogram of the blank electrode (no enzyme immobilized) in the 
presence and absence of TMAO. 
Figure S3: Direct bioelectrocatalysis of immobilized aerobically expressed and purified 
TorA-WT with TMAO as substrate. 
Figure S4: Amperometric curves for mediated bioelectrocatalysis. 
Figure S5: Amperometric curves for the blank electrode. 
Figure S6: Zoomed-in view of as-isolated TorA-WT EPR spectra.   
Figure S7: EPR spectral simulation of TorA-WT (-O2ex/-O2pur) in the as-isolated state. 
Figure S8: EPR spectral simulation of recTorAsulfidobis-MGDFDH in the as-obtained state. 
 S3 
Table S1: TorA spin concentrations used in EPR spectroscopy.  The concentrations of 
TorA were determined by UV-visible absorption spectroscopy, while concentration of bound 
Mo was determined through ICP-OES.  The spin concentrations were determined through use 
of the Matlab toolbox ?spincounting? from the obtained spectra and associated tune picture of 
the resonator. The reported percent spin relates the amount of spin to the amount of Mo 
present. 
 
TorA treatment TorA (?M) Spin (?M) Mo (?M) % Spin 
TorA-WT (Aerobic Expression/ Aerobic Purification) 
As-iso 356 4.5 121 3.7 
DT-reduced 317 4.6 108 4.3 
FeCN-oxidized 317 13.9 108 12.9 
TorA-WT (Anaerobic Expression/Aerobic Purification) 
As-iso 128 4.8 124 3.8 
DT-reduced 114 10.9 111 9.8 
FeCN-oxidized 114 2.8 111 2.5 
TorA-WT (Anaerobic Expression/ Anaerobic Purification) 
As-iso 129 3.8 124 3.1 
DT-reduced 114 12.3 111 11.1 
FeCN-oxidized 114 4.4 111 4.0 
Redox-Cycled TorA-WT (Anaerobic Expression/Aerobic Purification) 
As-iso 225 0.8 90 0.9 
DT-reduced 225 1.9 90 2.1 
recTorAsulfidobis-MGDFDH 
As-iso 127 2.4 15.4 15.6 
DT-reduced 114 2.6 13.9 18.7 
recTorAsulfidobis-MGDXDH 
As-iso 138 1.8 4.6 39.1 
DT-reduced 124 1.5 4.2 35.7 
TorAS191C (Anaerobic Expression/Aerobic Purification) 





Figure S1: Direct bioelectrocatalysis of active TorA variants with TMAO as substrate.  
Direct bioelectrocatalysis of immobilized (A) recTorAsulfidobis-MGDFDH (B) recTorAsulfidobis-
MGDXDH (C) TorA-S191C (-O2ex / -O2pur), with TMAO as substrate. The black traces show 
voltammograms recorded when no substrate is present and red traces measured in the presence 
of substrate in the measuring cell. The black arrow indicates the Eonset. Conditions: pH 6.5, 10 
mM phosphate buffer, 3 mM TMAO, scan rate 5 mV/s, under stirring conditions. 
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Figure S2: Cyclic voltammogram of the blank electrode (no enzyme immobilized) in the 
presence and absence of TMAO. The black traces show the voltammogram recorded when 
no substrate was present and the red traces were measured in the presence of substrate in the 
measuring cell. Conditions: pH 6.5, 10 mM phosphate buffer, 3 mM TMAO, scan rate 5 
mV/s, under stirring conditions. 
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Figure S3: Direct bioelectrocatalysis of immobilized aerobically expressed and purified 
TorA-WT with TMAO as substrate. The black traces show the voltammogram recorded 
when no substrate was present and the red traces were measured in the presence of substrate 
in the measuring cell. Conditions: pH 6.5, 10 mM phosphate buffer, 3 mM TMAO, scan rate 
5 mV/s, under stirring conditions. 
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Figure S4: Amperometric curves for mediated bioelectrocatalysis. 
(A) Immobilized TorA-WT anaerobically expressed and purified and (B) aerobically 
expressed and purified were measured in the presence of methyl viologen as mediator and 
TMAO as substrate. Conditions: pH 6.5, 10 mM phosphate buffer, 3 mM TMAO, 1 mM 
methyl viologen, potential applied -0.85 V, under stirring conditions. 
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Figure S5: Amperometric curves for the blank electrode.  The blank electrode (no enzyme 
immobilized) was measured in the presence of the mediator methyl viologen and TMAO. 
Conditions: pH 6.5, 10 mM phosphate buffer, 3 mM TMAO, 1 mM methyl viologen, 






Figure S6: Zoomed-in view of as-isolated TorA-WT EPR spectra. Zoomed-in view of the 
spectra shown in Figure 8A-C (top traces) of TorA-WT prepared under different conditions. 
Spectra were obtained at 80 K with 3.93 mW microwave power, 5 G modulation amplitude 





Figure S7: EPR spectral simulation of TorA-WT (-O2ex/-O2pur) in the as-isolated state.  
Experimental spectrum (black trace) represents the spectrum depicted in Figure 8C, top trace.  
Spectral simulation (red trace) was simulated as a one-component simulation, using the 
simulation toolbox EasySpin.  Simulation parameters: g: 1.987, 1.965, 1.941 (gav = 1.964, g1-







Figure S8: EPR spectral simulation of recTorAsulfidobis-MGDFDH in the as-obtained state.  
Experimental spectrum (black trace) represents the spectrum depicted in Figure 9A, bottom 
trace.  Spectral simulation (red trace) was simulated as a one-component simulation, using 
the simulation toolbox EasySpin.  Simulation parameters:  g: 1.997, 1.986, 1.967 (gav = 
1.983, g1-g3 = 0.030), g-strain: 5.0, 4.0, 4.9 (? 10-3). 
 
 
